THOUSAND OAKS BIOPHARMACEUTICALS
Thousand Oaks Biopharmaceuticals is a developer of biopharmaceutical technologies intended to produce protein and vaccine compounds. The company's technologies provide integrated control solutions, including the use of technical expertise to optimize the process and increase protein expression to reduce production scale, providing bio-pharmaceutical companies with personalized, chemical-defined cell culture media, formula production, technical support and ancillary services.
THOUSAND OAKS BIOPHARMACEUTICALS
Social Links:
Industry:
Biopharma Biotechnology Health Care
Founded:
2017-03-01
Status:
Active
Contact:
+86 0513-68067603
Email Addresses:
[email protected]
Total Funding:
2.2 B CNY
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Google Font API Content Delivery Network SSL By Default Mobile Non Scaleable Content Pound Sterling ASP.NET
Similar Organizations
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Nodexus
Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Transcenta
Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture.
Tridiuum
Tridiuum is a digital health company that is advancing the treatment of behavioral health conditions.
Current Employees Featured
Founder
Investors List
Timesbole
Timesbole investment in Venture Round - Thousand Oaks Biopharmaceuticals
CDH Investments
CDH Investments investment in Series D - Thousand Oaks Biopharmaceuticals
Highlight Capital
Highlight Capital investment in Series D - Thousand Oaks Biopharmaceuticals
GoldStone Investment
GoldStone Investment investment in Series D - Thousand Oaks Biopharmaceuticals
Hillhouse Investment
Hillhouse Investment investment in Series D - Thousand Oaks Biopharmaceuticals
Jinshi Investment
Jinshi Investment investment in Series C - Thousand Oaks Biopharmaceuticals
China State-Owned Capital Venture Investment Fund
China State-Owned Capital Venture Investment Fund investment in Series C - Thousand Oaks Biopharmaceuticals
CDH Investments
CDH Investments investment in Series C - Thousand Oaks Biopharmaceuticals
Honghui Capital
Honghui Capital investment in Series C - Thousand Oaks Biopharmaceuticals
GL Ventures LLC
GL Ventures LLC investment in Series C - Thousand Oaks Biopharmaceuticals
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-01-17 | MabPlex International | Thousand Oaks Biopharmaceuticals investment in Series A - MabPlex International | 400 M CNY |
More informations about "Thousand Oaks Biopharmaceuticals"
Thousand Oaks Biopharmaceuticals - PitchBook
Thousand Oaks Biopharmaceuticals General Information Description. Operator of a chemistry, manufacturing and controls (CMC) organization. The company offers contract development and manufacturing company (CDMO) services, …See details»
Thousand Oaks Biopharmaceuticals Completes $45 …
Jan 3, 2019 Thousand Oaks Biopharmaceuticals is a world-class integrated CMC organization which enables its partners to provide affordable and accessible biologics for patients worldwide.See details»
Thousand Oaks Biopharmaceuticals - Funding, Financials, …
Thousand Oaks Biopharmaceuticals is a developer of biopharmaceutical technologies intended to produce protein and vaccine compounds. Search Crunchbase. Start Free Trial . ... How much …See details»
Thousand Oaks Biopharmaceuticals - PharmaBoardroom
Feb 7, 2019 Thousand Oaks Biopharmaceuticals Last updated: 02.07.2019 Thousand Oaks focuses on process development service, GMP pilot and GMP commercial scale contract …See details»
Thousand Oaks Biopharmaceuticals Company Profile - Craft
Thousand Oaks Biopharmaceuticals has 5 employees across 2 locations and $107.6 m in total funding,. See insights on Thousand Oaks Biopharmaceuticals including office locations, …See details»
Thousand Oaks Biopharmaceuticals - Products, Competitors, …
Greater China Digest: GL Ventures co-leads Thousand Oaks round; Taiwan’s Influenxio bags $2m. Mar 10, 2021. Source: National Cancer Institute/Unsplash March 10, 2021 Thousand …See details»
Thousand Oaks Biopharmaceuticals Completes $45 Million Series …
Jan 4, 2019 THOUSAND OAKS, Calif. & SHANGHAI--(BUSINESS WIRE)--Thousand Oaks Biopharmaceuticals, Inc. (“TOBIO”), a leading integrated global CMC organization including …See details»
Thousand Oaks Biopharmaceuticals - 2021-03-10 - Crunchbase
Thousand Oaks Biopharmaceuticals raised $61482654 on 2021-03-10 in Series C. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. …See details»
Thousand Oaks Biopharmaceuticals Inc. - BioCentury
Nov 17, 2020 Thousand Oaks Biopharmaceuticals Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Thousand Oaks Biopharmaceuticals Inc - Company Profile and News
Company profile page for Thousand Oaks Biopharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»
China CDMO Thousand Oaks raises $240m - AVCJ
Nov 10, 2023 Thousand Oaks Biopharmaceuticals, a China-based contract development and manufacturing organization (CDMO), has raised CNY 1.5bn (USD 240m) in funding led by …See details»
Thousand OAKS Biopharma Secures Series A Total at USD 44 Million
January 1, 2019 /EqualOcean/ - Thousand OAKS Biopharmaceuticals(TOAKSB) just completed its series A funding total at CNY 300 million (USD 44 million) led by New Alliance Capital and …See details»
Shun Luo - Chairman, Founder and CEO, Thousand Oaks …
Dr Shun Luo, chairman, founder and CEO of Thousand Oaks Biopharmaceuticals, shares the company’s vision to deliver more accessible and affordable biologics to patients globally by …See details»
Thousand Oaks Biopharmaceuticals - Contacts, Employees, Board …
Thousand Oaks Biopharmaceuticals is a developer of biopharmaceutical technologies intended to produce protein and vaccine compounds. Search Crunchbase Start Free TrialSee details»
Thousand Oaks Biopharmaceuticals Completes $45 Million Series
Jan 11, 2019 Thousand Oaks Biopharmaceuticals, Inc. (“TOBIO”), a leading integrated global CMC organization including GMP cell culture media and biomanufacturing capabilities today …See details»
Thousand Oaks Biopharmaceuticals receives $45m in Series A …
Jan 14, 2019 Thousand Oaks Biopharmaceuticals raised $45m in Series A financing, enabling the company to expand its CDMO and CMC services as well as its capabilities in global …See details»
Thousand Oaks Biologics and GeneQuantum Healthcare Signed A …
May 22, 2023 TOBio is a cutting-edge global biopharmaceutical development and manufacturing organization, whose CMC capabilities in biologics are widely acknowledged. ... About …See details»
Thousand Oaks Biopharmaceuticals - Crunchbase
Jan 17, 2019 Thousand Oaks Biopharmaceuticals has invested in MabPlex International on Jan 17, 2019. This investment - Series A - MabPlex International - was valued at . obfuscated. …See details»
Thousand Oaks Biopharmaceuticals Raises $45M to Build Facility …
Jan 3, 2019 Thousand Oaks Biopharmaceuticals Inc. has closed a $45 million Series A financing round led by a Chinese investment group. Facebook Instagram Linkedin Twitter Youtube The …See details»